Claret Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Claret Asset Management's LLY Position: Q1 2026 in Review
Claret Asset Management reduced its Eli Lilly (LLY) stake by 0.31% in Q1 2026, selling an estimated $1.01K and leaving 318 shares worth $293K. The position accounts for 0.04% of the portfolio, ranked #195.
Claret Asset Management first reported a position in LLY in Q4 2017 and has held it in 21 quarters since. The position peaked at $3.9M in Q4 2019. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Claret Asset Management held 318 shares of Eli Lilly worth $293K as of Q1 2026.
- Claret Asset Management sold 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
- Eli Lilly made up 0.04% of Claret Asset Management's portfolio in Q1 2026, its #195 holding.
- Claret Asset Management first reported a position in Eli Lilly in Q4 2017 and has held it in 21 quarters since.
- Claret Asset Management's Eli Lilly position peaked at $3.9M in Q4 2019.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.